Cargando…

Psychosocial burden of type 1 and 2 hereditary angioedema: a single-center Canadian cohort study

BACKGROUND: Hereditary angioedema (HAE) is a rare but serious disorder associated with a multifaceted burden of illness including a high prevalence of psychiatric symptoms and impaired health-related quality of life (HRQoL). Despite recent efforts to clarify the psychosocial implications of HAE, imp...

Descripción completa

Detalles Bibliográficos
Autores principales: Hews-Girard, Julia, Goodyear, Marilyn Dawn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8244202/
https://www.ncbi.nlm.nih.gov/pubmed/34187550
http://dx.doi.org/10.1186/s13223-021-00563-0
_version_ 1783715884938821632
author Hews-Girard, Julia
Goodyear, Marilyn Dawn
author_facet Hews-Girard, Julia
Goodyear, Marilyn Dawn
author_sort Hews-Girard, Julia
collection PubMed
description BACKGROUND: Hereditary angioedema (HAE) is a rare but serious disorder associated with a multifaceted burden of illness including a high prevalence of psychiatric symptoms and impaired health-related quality of life (HRQoL). Despite recent efforts to clarify the psychosocial implications of HAE, important gaps still remain. The aim of this study was to characterize the psychosocial burden associated with HAE types 1 and 2. METHODS: Type 1 or 2 HAE patients (n  =  17), aged 19 years or older, completed the Depression, Anxiety, Stress Scale (DASS-21) and the DSM-5 cross cutting measures to identify psychiatric symptomatology, Angioedema Quality of Life Questionnaire (AE-QoL) and the Short-Form 36-Item Health Survey version 2 (SF-36v2) to assess disease-related and generic HRQoL respectively, and the Work Productivity and Activity Impairment Questionnaire (WPAI) to measure impact on work productivity and daily activities. Data analyses were conducted using SPSS statistical software (Version 25.0; IBM, Armonk, NY). Descriptive statistics were used to summarize continuous demographics and clinical characteristics and outcomes of interest while frequency distributions were used for categorical variables. T tests were used to compare SF-36v2 domain scores to Canadian norms and sex differences in scale scores. RESULTS: Depression [DASS-21 score  =  6.8  ±  10.2; n  =  12 (71%)] anxiety [DASS-21 score  =  6.2  ±  8.2; n  =  13 (76%)] and stress [DASS-21 score  =  10  ±  10.2; n  =  13 (76%)] were prevalent. Other psychiatric symptoms warranting inquiry included mania (n  =  14, 82.4%), anger (n  =  14, 82.4%), sleep disturbances (n  =  13, 76.5%), somatic symptoms (n  =  11, 64.7%) and impaired personality functioning (n  =  9, 52.9%). Mean AE-QoL score was 39  ±  18.2. Mean SF-36v2 domain scores were significantly lower than Canadian normative data for the entire sample (p  <  0.05). Impairment in work productivity was minimal; mean activity impairment was 20.6%  ±  21.1% [n  =  11 (64.7%)]. Female participants reported significantly greater HAE-related stress [DASS; t(15)  =   − 2.2, p  =  0.04], greater HAE-related fears [AEQoL; t(5.6)  =   − 2.7, p  =  0.04), and lower SF-36v2 domain scores than male patients. CONCLUSIONS: Study findings offer specific, valuable insight into the psychosocial burden of HAE with the potential to improve clinical management of HAE. Best practices for effective management of HAE should include providing holistic care to address the psychosocial and mental health of HAE patients.
format Online
Article
Text
id pubmed-8244202
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-82442022021-06-30 Psychosocial burden of type 1 and 2 hereditary angioedema: a single-center Canadian cohort study Hews-Girard, Julia Goodyear, Marilyn Dawn Allergy Asthma Clin Immunol Research BACKGROUND: Hereditary angioedema (HAE) is a rare but serious disorder associated with a multifaceted burden of illness including a high prevalence of psychiatric symptoms and impaired health-related quality of life (HRQoL). Despite recent efforts to clarify the psychosocial implications of HAE, important gaps still remain. The aim of this study was to characterize the psychosocial burden associated with HAE types 1 and 2. METHODS: Type 1 or 2 HAE patients (n  =  17), aged 19 years or older, completed the Depression, Anxiety, Stress Scale (DASS-21) and the DSM-5 cross cutting measures to identify psychiatric symptomatology, Angioedema Quality of Life Questionnaire (AE-QoL) and the Short-Form 36-Item Health Survey version 2 (SF-36v2) to assess disease-related and generic HRQoL respectively, and the Work Productivity and Activity Impairment Questionnaire (WPAI) to measure impact on work productivity and daily activities. Data analyses were conducted using SPSS statistical software (Version 25.0; IBM, Armonk, NY). Descriptive statistics were used to summarize continuous demographics and clinical characteristics and outcomes of interest while frequency distributions were used for categorical variables. T tests were used to compare SF-36v2 domain scores to Canadian norms and sex differences in scale scores. RESULTS: Depression [DASS-21 score  =  6.8  ±  10.2; n  =  12 (71%)] anxiety [DASS-21 score  =  6.2  ±  8.2; n  =  13 (76%)] and stress [DASS-21 score  =  10  ±  10.2; n  =  13 (76%)] were prevalent. Other psychiatric symptoms warranting inquiry included mania (n  =  14, 82.4%), anger (n  =  14, 82.4%), sleep disturbances (n  =  13, 76.5%), somatic symptoms (n  =  11, 64.7%) and impaired personality functioning (n  =  9, 52.9%). Mean AE-QoL score was 39  ±  18.2. Mean SF-36v2 domain scores were significantly lower than Canadian normative data for the entire sample (p  <  0.05). Impairment in work productivity was minimal; mean activity impairment was 20.6%  ±  21.1% [n  =  11 (64.7%)]. Female participants reported significantly greater HAE-related stress [DASS; t(15)  =   − 2.2, p  =  0.04], greater HAE-related fears [AEQoL; t(5.6)  =   − 2.7, p  =  0.04), and lower SF-36v2 domain scores than male patients. CONCLUSIONS: Study findings offer specific, valuable insight into the psychosocial burden of HAE with the potential to improve clinical management of HAE. Best practices for effective management of HAE should include providing holistic care to address the psychosocial and mental health of HAE patients. BioMed Central 2021-06-29 /pmc/articles/PMC8244202/ /pubmed/34187550 http://dx.doi.org/10.1186/s13223-021-00563-0 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Hews-Girard, Julia
Goodyear, Marilyn Dawn
Psychosocial burden of type 1 and 2 hereditary angioedema: a single-center Canadian cohort study
title Psychosocial burden of type 1 and 2 hereditary angioedema: a single-center Canadian cohort study
title_full Psychosocial burden of type 1 and 2 hereditary angioedema: a single-center Canadian cohort study
title_fullStr Psychosocial burden of type 1 and 2 hereditary angioedema: a single-center Canadian cohort study
title_full_unstemmed Psychosocial burden of type 1 and 2 hereditary angioedema: a single-center Canadian cohort study
title_short Psychosocial burden of type 1 and 2 hereditary angioedema: a single-center Canadian cohort study
title_sort psychosocial burden of type 1 and 2 hereditary angioedema: a single-center canadian cohort study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8244202/
https://www.ncbi.nlm.nih.gov/pubmed/34187550
http://dx.doi.org/10.1186/s13223-021-00563-0
work_keys_str_mv AT hewsgirardjulia psychosocialburdenoftype1and2hereditaryangioedemaasinglecentercanadiancohortstudy
AT goodyearmarilyndawn psychosocialburdenoftype1and2hereditaryangioedemaasinglecentercanadiancohortstudy